Labor Day specimen shipment alert - Insights
Due to the Labor Day holiday (recognized on Monday, September 6), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.
This “Specialty Testing” webinar will discuss the collaborative effort which led to the discovery of Kelch like protein 11 (KLHL11) IgG as a specific biomarker of neurological autoimmunity associated testicular germ cell tumor.
Pediatric CNS Disorder Evaluations [Test in Focus] - Insights
Autoimmune encephalitis and myelitis is increasingly recognized as a cause of CNS disease in children and teens. Andrew McKeon, M.B., B.Ch., M.D, gives an overview of this test available through Mayo Clinic Laboratories. He discusses when...
Update on 2021 WHO classification of lung tumors - Insights
In this month’s “Hot Topic,” Anja Roden, M.D., discusses new entities and changes of terminology in the 2021 World Health Organization (WHO) classification of lung tumors as well as the nomenclature in small biopsies.
MCL Cytogenetics Tech Only HER2 Paraffin Testing Patient Information MC1235203
MCL Cytogenetics Tech HER2 Paraffin Testing Patient Information Complete print Cytogenetics Tech HER2 Paraffin Testing Patient Information Patient Information Patient Middle Patient ID
Sarcoma Informative Cases - Insights
Case #1 Case #2 Case #3 Case #4 Case #5 Sarcomas are malignant tumors that arise in the bone and soft tissue. With numerous subtypes of sarcoma that can
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.
In this month's "Hot Topic," Robin Patel, M.D., discusses how the use of multiplex tests may reduce the turnaround time for identifying the cause of bloodstream infections, and how this might impact antibiotic stewardship and patient...
Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.